Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-07 5:29 pm Purchase | 2022-09-27 | 13G | TREVI THERAPEUTICS INC TRVI | VIKING GLOBAL INVESTORS LP | 5,984,734 9.990% | 5,984,734 (New Position) | Filing History |
| 2022-09-19 5:08 pm Purchase | 2022-09-07 | 13D | CAZOO GROUP LTD CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.300% | 30,000 (New Position) | Filing History |
| 2022-09-09 9:50 pm Sale | 2022-09-08 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | VIKING GLOBAL INVESTORS LP | 5,770,536 9.900% | -1,400,000 (-19.52%) | Filing History |
| 2022-07-01 5:00 pm Purchase | 2022-06-28 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | VIKING GLOBAL INVESTORS LP | 2,877,103 9.700% | 1,600,724 (+125.41%) | Filing History |
| 2022-06-10 4:15 pm Purchase | 2022-05-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | VIKING GLOBAL INVESTORS LP | 2,366,385 5.100% | 2,366,385 (New Position) | Filing History |
| 2022-05-20 4:15 pm Purchase | 2022-05-10 | 13G | PEPGEN INC PEPG | VIKING GLOBAL INVESTORS LP | 1,793,923 8.000% | 1,793,923 (New Position) | Filing History |
| 2022-04-14 5:09 pm Purchase | 2022-04-04 | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 8,103,527 9.500% | 8,103,527 (New Position) | Filing History |
| 2022-03-22 5:18 pm Sale | 2022-03-18 | 13G | PROCEPT BIOROBOTICS CORP COM PRCT | VIKING GLOBAL INVESTORS LP | 3,658,892 8.400% | -1,249,000 (-25.45%) | Filing History |
| 2022-03-04 5:21 pm Sale | 2022-03-02 | 13D | GINKGO BIOWORKS HOLDINGS INC C DNA | VIKING GLOBAL INVESTORS LP | 1,276,379 4.990% | -6,297,195 (-83.15%) | Filing History |
| 2022-02-14 5:03 pm Sale | 2021-12-31 | 13G | NUANCE COMMUNICATIONS INC NUAN | VIKING GLOBAL INVESTORS LP | 0 0.000% | -16,382,663 (Position Closed) | Filing History |
| 2022-02-14 5:03 pm Sale | 2021-12-31 | 13G | FIGS INC FIGS | VIKING GLOBAL INVESTORS LP | 13,340,414 8.800% | -1,602,275 (-10.72%) | Filing History |
| 2022-02-14 5:02 pm Unchanged | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | VIKING GLOBAL INVESTORS LP | 3,937,914 12.300% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:02 pm Purchase | 2021-12-31 | 13G | ORION ACQUISITION CORP OHPA | VIKING GLOBAL INVESTORS LP | 3,669,272 8.900% | 69,272 (+1.92%) | Filing History |
| 2022-02-14 5:02 pm Unchanged | 2021-12-31 | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 21.300% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:02 pm Sale | 2021-12-31 | 13G | ATHIRA PHARMA INC ATHA | VIKING GLOBAL INVESTORS LP | 0 0.000% | -212,065 (Position Closed) | Filing History |
| 2022-02-14 5:02 pm Unchanged | 2021-12-31 | 13G | INHIBRX INC INBX | VIKING GLOBAL INVESTORS LP | 5,305,866 14.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:02 pm Sale | 2021-12-31 | 13G | EDGEWISE THERAPEUTICS INC EWTX | VIKING GLOBAL INVESTORS LP | 2,727,249 5.500% | -625,032 (-18.64%) | Filing History |
| 2022-02-14 5:02 pm Sale | 2021-12-31 | 13G | MUDRICK CAP ACQUISITION CORP I MUDS | VIKING GLOBAL INVESTORS LP | 0 0.000% | -3,047,904 (Position Closed) | Filing History |
| 2022-02-14 5:01 pm Purchase | 2021-12-31 | 13G | PHARVARIS N V REGISTERED PHVS | VIKING GLOBAL INVESTORS LP | 2,455,536 7.400% | 35,381 (+1.46%) | Filing History |
| 2022-02-14 5:01 pm Sale | 2021-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | VIKING GLOBAL INVESTORS LP | 1,790,284 3.900% | -573,778 (-24.27%) | Filing History |